Medical care expenditures for genital herpes in the United States

Sexually Transmitted Diseases

Volumn 27, Issue 1, 2000, Pages 32-38

  Tao, Guoyu ^a   Kassler, William J ^a   Rein, David B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; CESAREAN SECTION; CHILD; FEMALE; GENITAL HERPES; HEALTH CARE COST; HEALTH INSURANCE; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAID; SERODIAGNOSIS; UNITED STATES;

EID: 0033977355     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200001000-00007     Document Type: Article

References (35)

1. Fleming DT, McQuillan GM, Johnson RE, et al. The evolving epidemiology of herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1107
2. Whitley RJ. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci 1994;91:2441-2447.
3. Centers for Disease Control and Prevention, DSTD/HIVP (Divison of STD/HIV Prevention). Annual report 1994. U.S. Department of Health and Human Services, Public Health Services. Atlanta: Centers for Disease Control and Prevention. 1995;78,98.
4. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Broods CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989;321: 7-12.
5. Chuang TY. Neonatal herpes: incidence, prevention, and consequences. Am J Prev Med 1988;4(1):47-53.
6. Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1995. Atlanta, GA: Centers for Disease Control and Prevention, Public Health Services, U.S. Department of Health and Human Services. 1996:30.
7. Siegel JE Estimates of the economic burden of STDs: review of the literature with updates. In: Eng TR, Butler WT, eds. The Hidden Epidemic. Washington, D.C., National Academy Press, 1997:330-356.
8. Institute of Medicine (IOM). New vaccine development: establishing priorities; vol. I, Diseases of importance in the United States. Washington, DC: National Academy Press, 1985:280-312.
9. Simmons WR, Schnack GA. Development of the design of the NCHS Hospital Discharge Survey. National Center for Health Statistics. Vital Health Stat 1970;2(39):1-16.
10. Graves EJ. National hospital discharge survey: annual summary, 1992. National Center for Health Statistics. Vital Health Stat 1994;13(119): 1-2,53-61.
11. McCaig LF McLemore T. Plan and operation of the national hospital ambulatory medical care survey, 1992. National Center for Health Statistics. Vital Health Stat 1994;1(34)1-16.
12. IMS America. National Disease and Therapeutic Index (NDTI): Diagnosis Volume 1, Jan. 1992-Dec. 1992. Plymouth Meeting, PA: IMS America, 1993:1-40.
13. IMS America. Pharmaceutical Database Reference Manual: July 1992 Updated Edition. Plymouth Meeting, PA: IMS America, 1992:8-16.
14. Landry DJ, Forrest JD. Public health departments providing sexually transmitted disease services. Fam Plan Perspect 1996;28: 261-266.
15. Ventura SJ, Martin JA, Taffel SM, et al. Advance report of final natality statistics, 1992. Monthly Vital Statistics Report. Nat Center Health Stat 1994;43(suppl):1-90.
16. American Medical Association (AMA). International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Chicago, IL: American Medical Association, 1996.
17. American Medical Association (AMA). Physicians' Current Procedural Terminology, 1996 (CPT'96). Chicago, IL: American Medical Association, 1996.
18. Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions: efficacy, risks, and costs. JAMA 1993;270(1):77-82.
19. Mennemeyer ST, Cyr LP, Whitley RJ. Antiviral therapy for neonatal herpes simplex virus: a cost-effectiveness analysis. Am J Managed Care 1997;3:1551-1558.
20. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mort Wkly Rep 1998;47(No. RR-1):20-26.
21. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997;349:1868-1873.
22. Crosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 1995;346:530-536.
23. Schacker T, Ryncarz AJ, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected men. JAMA 1998;280:61-66.
24. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2(8660):403-407.
25. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997;11:F85-F93.
26. Straus SE, Corey L, Burke RL, et al. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 1994;343: 1460-1463.
27. Bourne N, Stanberry LR, Bernstein DI, Lew D. DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 1996;173:800-807.
28. The International Working Group on Vaginal Microbicides. Recommendations for the development of vaginal microbicides. AIDS 1996;18(8):UNAIDS1-UNAIDS6.
29. Whitley RJ. Herpes simplex virus infection. In: Remington J, Klein J, eds. Infectious Diseases of the Fetus and Newborn Infants. Philadelphia, PA: WB Saunders, 1990:283-305.
30. Nahmias AJ, Keserling HK, Kerrick GM, et al. Herpes simplex. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia, PA: WB Saunders, 1983:638.
31. Sullivan-Bolyai J, Hull HF, Wilson C, et al. Neonatal herpes simplex virus infection in King County, Washington: increasing incidence and epidemiologic correlates. JAMA 1983;250:3059.
32. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR Morb Mort Wkly Rep 1993; 42(RR-14):22-26.
33. Gibbs RS, Amstey MS, Lezotte DC. Role of cesarean delivery in preventing neonatal herpes virus infection. JAMA 1993;270:94-95.
34. Smucker DR, Thomas JC. Evidence of thorough reporting of sexually transmitted diseases in a southern rural county. Sex Transm Dis 1995;22(3):149-154.
35. Rice D. Herpes and health insurance. The Helper 1994;16(1):1-9.